washingtonpost.com - Human Genome Scienceshttp://www.washingtonpost.com/wp-dyn/technology/washtech/companies/hgs?nav=rss_technology/washtech/companies/hgsHuman Genome Sciencesen-us15washingtonpost.com14020http://www.washingtonpost.comhttp://media.washingtonpost.com/wp-srv/hp/image/wp_web.gif<![CDATA[HGS Arthritis Drug Clears Testing Hurdle]]>http://www.washingtonpost.com/wp-dyn/articles/A28494-2005Apr5.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A28494-2005Apr5.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT Michael S. Rosenwald<![CDATA[It's Crunch Time for Biotech Companies]]>http://www.washingtonpost.com/wp-dyn/articles/A42854-2005Jan2.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A42854-2005Jan2.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT Michael S. Rosenwald<![CDATA[HGS Picks Watkins as New Chief Executive]]>http://www.washingtonpost.com/wp-dyn/articles/A3115-2004Nov21.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A3115-2004Nov21.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-The Washington Post]]> Michael S. Rosenwald<![CDATA[HGS Board Member Named Chairman]]>http://www.washingtonpost.com/wp-dyn/articles/A36881-2004Sep20.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A36881-2004Sep20.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-TheWashington Post]]> Michael S. Rosenwald<![CDATA[No Favorite in Race to Treat Lupus]]>http://www.washingtonpost.com/wp-dyn/articles/A64190-2004Sep5.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A64190-2004Sep5.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-The Washington Post]]> Michael S. Rosenwald<![CDATA[Bioshield Too Little for Drug Industry]]>http://www.washingtonpost.com/wp-dyn/articles/A13873-2004Jul25.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A13873-2004Jul25.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-The Washington Post]]> Michael Barbaro<![CDATA[Panel Cuts Bush's Budget Request for NASA]]>http://www.washingtonpost.com/wp-dyn/articles/A64974-2004Jul20.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A64974-2004Jul20.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT Guy Gugliotta and Dan Morgan<![CDATA[U.S. to Order Anthrax Vaccine]]>http://www.washingtonpost.com/wp-dyn/articles/A23388-2004Jun7.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A23388-2004Jun7.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-The Washington Post]]> Justin Gillis<![CDATA[Book Your Seat for Venus Transit]]>http://www.washingtonpost.com/wp-dyn/articles/A8108-2004Jun1.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A8108-2004Jun1.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT Blaine P. Friedlander Jr.<![CDATA[HGS Cutting Staff, CEO Haseltine Retiring]]>http://www.washingtonpost.com/wp-dyn/articles/A22227-2004Mar24.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A22227-2004Mar24.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-The Washington Post]]> Justin Gillis and Yuki Noguchi<![CDATA[U.S. to Buy Anthrax Vaccine Stockpile]]>http://www.washingtonpost.com/wp-dyn/articles/A51691-2004Mar11.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A51691-2004Mar11.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT Justin Gillis<![CDATA[Anthrax Treatment Successes Reported]]>http://www.washingtonpost.com/wp-dyn/articles/A43087-2004Mar9.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A43087-2004Mar9.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-The Washington Post]]> Justin Gillis<![CDATA[Anthrax Treatments Promising in Tests]]>http://www.washingtonpost.com/wp-dyn/articles/A41548-2004Mar8.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A41548-2004Mar8.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-The Washington Post]]> Justin Gillis<![CDATA[Firm Abandoning Drug]]>http://www.washingtonpost.com/wp-dyn/articles/A7273-2004Feb2.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A7273-2004Feb2.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-The Washington Post]]> Michael Barbaro<![CDATA[Human Genome Sciences Cuts Workforce by 7%]]>http://www.washingtonpost.com/wp-dyn/articles/A9616-2003Dec17.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A9616-2003Dec17.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT Michael Barbaro<![CDATA[The High Cost Of Making an Anthrax Drug]]>http://www.washingtonpost.com/wp-dyn/articles/A43948-2003Dec7.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A43948-2003Dec7.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-The Washington Post]]> Michael Barbaro<![CDATA[Human Genome Sciences Cuts Losses]]>http://www.washingtonpost.com/wp-dyn/articles/A31646-2003Oct28.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A31646-2003Oct28.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-The Washington Post]]> Michael Barbaro<![CDATA[Human Genome Sciences to Abandon Key Treatment]]>http://www.washingtonpost.com/wp-dyn/articles/A2196-2003Sep25.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A2196-2003Sep25.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT Michael Barbaro<![CDATA[HGS Still Waiting for Drug Pipeline to Pay Off]]>http://www.washingtonpost.com/wp-dyn/articles/A62124-2003Jul29.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A62124-2003Jul29.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT Michael Barbaro<![CDATA[Biotech Firm Revises Financing]]>http://www.washingtonpost.com/wp-dyn/articles/A29539-2003Jul8.html?nav=rss_technology/washtech/companies/hgshttp://www.washingtonpost.com/wp-dyn/articles/A29539-2003Jul8.html?nav=rss_technology/washtech/companies/hgsThu, 28 Apr 2005 23:03:39 GMT-The Washington Post]]> Michael Barbaro